Kainate receptor-selective epimeric analogs of dysiherbaine
Disclosed are compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a GluR5 receptor, a GluR6 receptor, or both receptors. The pharmaceutical compositions include and the methods utilize compounds that are analogs and stereoisomers of dysiherbaine and neodysiherbaine which have specificity for kainate receptors.
1. A pharmaceutical composition comprising:
(a) a compound having the formula
and
(b) one or more pharmaceutically acceptable carriers, diluents, or excipients.
2. The composition of claim 1 , wherein the composition is suitable for administration to a human.
3. The composition of claim 1 , wherein the composition is suitable for oral administration.
4. The composition of claim 1 , wherein the composition is suitable for transdermal administration.